Pfizer
Pfizer Share Price Chart
Pfizer last traded at ₹3,860.10 (2026-10-13). Over the past month the stock moved -5.8%, three months the stock moved -16.8%, year the stock moved -24.4%. Its closing range over 52 weeks is ₹3,732.00 – ₹5,354.00, with the latest close 27.9% below the high.
Closing prices up to 2026-10-13.
About Pfizer
Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also has various independent contract/ third party manufacturers based across the country and sells its products through independent distributors primarily in India.[1] It is the 3rd largest multinational pharmaceutical company in India.[2]
Parentage The company is a subsidiary of Pfizer Inc. one of the world’s leading biopharma companies with a presence in over 125 countries. Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. [1] [2]
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Pfizer reported sales of ₹653.00 crore (+8.3%) and net profit of ₹204.00 crore (+6.3%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 653.00 | 248.00 | 38.00 | 204.00 | 44.70 |
| Mar 2026 | 629.00 | 236.00 | 38.00 | 200.00 | 43.68 |
| Dec 2025 | 645.00 | 228.00 | 35.00 | 142.00 | 31.00 |
| Sep 2025 | 642.00 | 230.00 | 36.00 | 189.00 | 41.32 |
| Jun 2025 | 603.00 | 210.00 | 35.00 | 192.00 | 41.91 |
| Mar 2025 | 592.00 | 228.00 | 38.00 | 331.00 | 72.34 |
| Dec 2024 | 538.00 | 146.00 | 27.00 | 128.00 | 27.89 |
| Sep 2024 | 589.00 | 189.00 | 32.00 | 158.00 | 34.61 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +2.4% | -0.4% | +8.2% | +7.1% | +9.0% | +19.9% | +6.3% | +8.3% |
| Operating profit growth | +3.3% | -4.6% | +20.6% | +18.6% | +21.7% | +56.2% | +3.5% | +18.1% |
| Net profit growth | +6.0% | -1.5% | +84.9% | +27.2% | +19.6% | +10.9% | -39.6% | +6.3% |
| EPS growth | +6.3% | -1.8% | +85.0% | +27.2% | +19.4% | +11.2% | -39.6% | +6.7% |
| OPM % | 32.0% | 27.0% | 38.0% | 35.0% | 36.0% | 35.0% | 38.0% | 38.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Pfizer reported sales of ₹2,520.00 crore (+10.5%) and net profit of ₹722.00 crore (-6.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 2,520 | 904.00 | 36.00 | 722.00 | 157.92 |
| Mar 2025 | 2,281 | 742.00 | 33.00 | 768.00 | 167.79 |
| Mar 2024 | 2,193 | 638.00 | 29.00 | 551.00 | 120.52 |
| Mar 2023 | 2,425 | 809.00 | 33.00 | 624.00 | 136.38 |
| Mar 2022 | 2,611 | 836.00 | 32.00 | 613.00 | 133.90 |
| Mar 2021 | 2,239 | 712.00 | 32.00 | 498.00 | 108.77 |
| Mar 2020 | 2,152 | 574.00 | 27.00 | 509.00 | 111.29 |
| Mar 2019 | 2,082 | 566.00 | 27.00 | 429.00 | 93.79 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +5.7% | +3.4% | +4.0% | +16.6% | -7.1% | -9.6% | +4.0% | +10.5% |
| Operating profit growth | +13.0% | +1.4% | +24.0% | +17.4% | -3.2% | -21.1% | +16.3% | +21.8% |
| Net profit growth | +19.2% | +18.6% | -2.2% | +23.1% | +1.8% | -11.7% | +39.4% | -6.0% |
| EPS growth | +19.2% | +18.7% | -2.3% | +23.1% | +1.9% | -11.6% | +39.2% | -5.9% |
| OPM % | 27.0% | 27.0% | 32.0% | 32.0% | 33.0% | 29.0% | 33.0% | 36.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Pfizer.
Get Free AI Stock Analysis FREE →Latest News
-
Pfizer Q2FY26 Results: Revenue tops estimates, guidance raised by $500 million - scanx.trade
-
Pfizer Q2FY26 Results: Revenue tops estimates, guidance raised by $500 million - scanx.trade
-
Novartis India Hits Record High After ₹1,250 Crore Pfizer Deal - whalesbook.com
-
Novartis-Pfizer trademark deal has opposite impact on their stock prices; Novartis India jumps 20% while Pfizer slips 3% - BusinessLine
-
Novartis India To Acquire Pfizer’s ‘Minipress’ Trademark for Rs 1,250 Crore
-
Nuvama Analysts Highlight Technical Setups in Ambuja, Asahi, Pfizer - Whalesbook
-
Nuvama Analysts Highlight Technical Setups in Ambuja, Asahi, Pfizer - Whalesbook
-
Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer - Pfizer
-
Pfizer Ltd. Stock Hits 52-Week Low at Rs.4450 Amidst Broad Market Weakness
-
Pfizer standalone net profit declines 39.62% in the March 2026 quarter - Business Standard
Frequently Asked Questions
What is the share price of Pfizer today?
Pfizer shares were last quoted at ₹3,860.10 (+1.4% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Pfizer?
Pfizer has a price-to-earnings (P/E) ratio of 24.92 and a price-to-book (P/B) ratio of 4.16. The industry P/E is 53.33.
What is the 52-week high and low of Pfizer?
The 52-week high of Pfizer is ₹5,561.55 and the 52-week low is ₹3,962.00.
What is the market cap of Pfizer?
The market capitalisation of Pfizer is about ₹18,323.34 crore.
How did Pfizer perform in its latest quarterly results?
In the latest quarter (Jun 2026), Pfizer reported sales of ₹653.00 crore (+8.3%) and net profit of ₹204.00 crore (+6.3%), compared with the same quarter last year.
Is Pfizer a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Pfizer has a 3-year ROE of 16.00%, 3-year profit growth of 8.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Pfizer?
Promoters hold about 63.92% of Pfizer.
Which sector does Pfizer belong to?
Pfizer belongs to the Pharmaceuticals & Drugs sector.